Florian Ludwig - Profile and Investment Details

Investor Profile

Florian Ludwig is a Venture Capital, Private Equity Firm, Micro VC based in Hilversum, North Holland, The Netherlands with a diverse investment portfolio that includes companies such as Intercell, Coley Pharmaceutical Group, TheraSolve, Salvia BioElectronics, Drug Abuse Sciences, Nightbalance, Develogen AG, Indigo Diabetes, Cristal Therapeutics, Omrix Biopharmaceuticals, Vernalis, Rox Medical, MILabs, Hemics, Direct Flow Medical®, Inc.FABPulous, Ingenium Pharmaceuticals AG, EnCare Biotech, Bioceros, Galapagos, DCPrime, ATRO Medical, Covidien, Synerkine Pharma, Mellon Medical, Breonics, Avantium Technologies, NutriLeads, Enanta Pharmaceuticals, Okapi Sciences, arGEN-X, EpiCept Corporation, Curacyte AG, Cavadis, . Over time, Florian Ludwig has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Florian Ludwig is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Sports, Wellness, Consumer Goods, Life Science, Medical Technologies, Information Technology (IT), Diabetes, Software, Manufacturing, Biotechnology, Medical Devices, Fashion, Food and Beverage, Digital Health, Medical, Sensors, Information Technology, Therapeutics may find it worthwhile to explore potential connections with Florian Ludwig, as their portfolio suggests a familiarity and interest in this area.

Understanding Florian Ludwig’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.